Meghna Deshraj

In this conversation, Wendy Slone, PhD, discusses her journey as an entrepreneur and the development of her company, BTEC, which focuses on innovative wound care solutions through the Halcyon Smart Patch. She emphasizes the importance of healing from within, the challenges of entrepreneurship, and the significance of building relationships and networking. Wendy also shares her insights on empowerment, particularly for women in business, and the need for a strong support system.Chapters:00:13 Introducing Dr. Wendy Sloan & B-Tech01:13 The Halcyon Smart Patch: Healing from the Inside Out02:02 The Personal Spark Behind B-Tech03:32 From NASA to Public Policy: Dr. Sloan’s Journey06:26 Far Infrared Light, Explained07:58 The Chronic Wound Care Crisis10:00 The Hidden Burden of Chronic Wounds13:51 B-Tech’s Buzz & Upcoming Human Trials15:06 Real-World Potential: Animals, Space & Defense18:53 Growing B-Tech: Early Lessons & Challenges20:07 Why Strategy Matters More Than Just the Product27:26 Building Investor Trust & Strategic Partnerships33:04 Mentorship, Boldness & Breaking Barriers36:09 Owning the Room & Overcoming Imposter Syndrome41:18 Resilience, Community & Entrepreneurial Grit43:05 Final Reflections on a Remarkable JourneyGuest Information:Guest's Name: Dr Wendy Slone Guest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/wendy-s-ba02b240/Company / Affiliation: bTECH https://btechls.com/Guest's Bio: Dr. Wendy Slone is the founder and CEO of bTECH Inc., where she leads the development of the Halcyon SMART Patch—a wearable healing technology designed to revolutionize chronic wound care. Inspired by her mother’s experience with diabetic ulcers, Dr. Slone combines personal passion with deep scientific expertise. She holds a Ph.D. in public policy, is pursuing a second doctorate in chemistry, and brings over 15 years of experience in data analytics and entrepreneurship. Her mission is clear: to transform outcomes for patients facing chronic wounds through innovation, science, and purpose-driven leadership.Takeaways:BTEC's Halcyon Smart Patch focuses on healing wounds from the inside out.Microcirculation is crucial for effective wound healing.The wound care industry is often overlooked despite its significance.Entrepreneurship involves navigating various challenges and obstacles.Building a solid business model is essential for success.Networking and building relationships are key to finding investors.Women entrepreneurs often face unique challenges and need support.It's important to maintain a positive attitude and resilience in business.Asking questions and challenging the status quo is vital for growth.Creating a core support system can significantly impact an entrepreneur's journey.

In this episode, Aimee Taylor, Founder and CEO of Alt Digital Marketing, shares her journey from traditional television marketing to the digital landscape, emphasizing the importance of strategy, authenticity, and client engagement in marketing. She discusses the evolving role of AI and SEO, the significance of human connection in marketing, and the challenges faced in healthcare marketing. Aimee also provides valuable insights for aspiring marketers, highlighting the need for hiring the right talent and the importance of transparency with clients.Chapters:00:00 Introduction to Digital Marketing and Transition from Traditional Media05:02 The Importance of Strategy in Marketing09:53 Navigating the AI Landscape in Marketing15:02 Understanding SEO and Its Evolution19:59 The Role of Websites in Modern Marketing24:47 The Role of Human Operators in Marketing25:42 Authenticity and Credibility in the Digital Age27:05 Navigating Google Business Profiles28:54 The Importance of Local SEO and Reviews30:39 The Value of Human Connection in Marketing32:58 Understanding the Client's Journey34:54 The Impact of Call Tracking on Business36:23 Healthcare Marketing: A Shift in Consumer Behavior38:51 The Future of Preventative Healthcare40:25 Adapting to AI in Marketing42:07 Leadership and Team Dynamics in Marketing46:35 Advice for Aspiring MarketersGuest Information:Guest's Name:  Aimee TaylorGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/aimee-taylor/Company/Affiliation: Alt Digital Marketing https://altdigitalmarketing.com/Guest's Bio: Aimee Taylor is the Founder and CEO of Alt Digital Marketing, a company that specializes in medical marketing with particular emphasis on the aesthetics industry. Aimee has over 13 years of digital marketing experience, which is bolstered by two decades of broadcast TV sales. She has a deep understanding of all aspects of digital and traditional marketing. She has a BA in Telecommunications from Indiana University, Bloomington, IN.Takeaways:Digital marketing offers more trackable results compared to traditional media.Strategy is crucial in navigating the complex marketing landscape.Clients need to niche down to effectively market their services.AI is reshaping marketing, but human oversight remains essential.Authenticity and credibility are vital for successful marketing campaigns.The website serves as the foundation for all marketing efforts.Engagement with clients enhances the effectiveness of marketing strategies.Healthcare marketing is evolving towards a focus on wellness and preventative care.Effective leadership involves hiring the right people and fostering a positive team culture.

In this conversation, Mary Hames, CEO and founder of BioLogic Pharma Solutions, discusses her journey in the biotech and pharmaceutical consulting industry. She explains the fractional model of consulting, which allows smaller companies to access expertise without the financial burden of hiring full-time staff. Mary shares her entrepreneurial journey, the importance of company culture, and the challenges of consulting in a dynamic environment. She also highlights the significance of trust in startups and her aspirations for the future of her company.00:00 Introduction to BioLogic Pharma Solutions03:01 The Fractional Model in Biotech Consulting06:00 Navigating Uncertainty in Drug Development09:04 Mary's Entrepreneurial Journey11:50 Vision for the Future of Biotech Consulting14:45 Challenges in Consulting and Growth17:57 The Importance of Trust in Entrepreneurship26:49 The Importance of Delegation in Business28:02 Navigating Client Acquisition and Marketing Strategies30:35 Effective Client Engagement and Presentation Techniques34:12 Understanding Market Dynamics and Client Feedback36:11 Identifying the Sweet Spot in the Drug Development Process39:25 Building a Flexible Workforce and Consultant Relationships40:19 Future Aspirations and Growth Strategies for the Company46:12 Reflections on the Entrepreneurial JourneyGuest Information:Guest's Name: Mary Hames Guest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/Company / Affiliation: BioLogic Pharma Solutions https://biologicpharmasolutions.com/Guest's Bio: Mary Hames is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency. Takeaways:The fractional model allows companies to access expertise without full-time hires.Building a company culture is essential for employee satisfaction.Consulting can be lonely, but teamwork helps mitigate that.Marketing strategies include presentations and SEO efforts.Trust is crucial for entrepreneurs to delegate responsibilities.The future of BioLogic includes becoming a go-to firm for pre-commercial products.Navigating uncertainty in drug development is a common challenge.Mary's entrepreneurial journey includes learning from past failures.The sweet spot for consulting is between phase two and three of drug development.

In this episode, Dr. Paula Muto shares her journey as a surgeon and entrepreneur, discussing her experiences in the medical field and the founding of UberDoc, a platform designed to provide patients with direct access to healthcare professionals. She emphasizes the importance of leadership, teamwork, and the challenges faced by women in medicine. Dr. Muto also highlights the need for innovation in healthcare and how UberDoc aims to empower patients by simplifying access to medical care.00:00 Introduction to Dr. Paula Muto and Her Journey02:33 Building the Muto Vein Center: A Personal Journey04:26 Leadership in Healthcare: Building a Strong Team07:06 Challenges in Modern Medicine: The Human Element09:38 Gender Disparities in Surgery: A Personal Perspective12:01 The Evolution of Surgical Practices and Technology12:46 Introducing UberDoc: A Solution for Patient Access15:55 The UberDoc Model: Direct Access to Care20:23 Insurance and Flexibility: The Future of Healthcare22:24 Overcoming Resistance: The Journey of UberDoc26:09 Expanding the Network: The Growth of UberDoc28:16 Streamlining Patient Appointments31:18 The Evolution of Telemedicine34:59 Building the UberDoc Team38:17 Funding and Expansion Strategies40:52 The Future of Direct Pay Healthcare45:03 Reimagining Patient CareGuest Information:Guest's Name:  Paula MutoGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/paulamutomd/Company/Affiliation:  UBERDOC - https://uber-docs.com/Guest's Bio: UBERDOC Founder and CEO Paula M. Muto, MD FACS, is a practicing vascular and general surgeon in solo practice and the owner of Muto Vein Center. She is a member of a family of physicians and surgeons who have collectively practiced medicine in Massachusetts for over 50 years. She is an outspoken advocate for patient care and is passionate about women’s health issues. Takeaways:Dr. Muto comes from a long line of surgeons and is passionate about restoring healthcare.Leadership in healthcare requires understanding and flexibility with team dynamics.Women in medicine face unique challenges, including compensation disparities.The healthcare system often prioritizes billing over patient care, leading to inefficiencies.UberDoc was created to solve the problem of access to healthcare for patients.The UberDoc model allows patients to pay directly for appointments, bypassing insurance complexities.Building a strong team is crucial for the success of any healthcare venture.Direct pay models are gaining traction as a solution to healthcare access issues.The future of healthcare may involve more technology and patient empowerment.Dr. Muto encourages collaboration among healthcare professionals to improve patient outcomes.

In this episode, Heath Fletcher and Kevin Scanlon delve into the intricacies of entrepreneurship, investment, and the vital role of character and team dynamics in achieving success. They discuss the importance of mentorship, the challenges entrepreneurs face in communicating with investors, and the significance of trust in business relationships. Kevin shares insights from his extensive experience in angel investing and teaching entrepreneurship, highlighting the need for adaptability and the ability to pivot in the face of challenges. The conversation also touches on the differences in investment environments across regions and the importance of a strong team over a perfect product.00:00 Introduction and Background01:50 Navigating the Science and Business Divide05:46 The Role of Angel Investors09:51 Teaching Entrepreneurship13:38 Trust and Team Dynamics in Startups17:38 Investment Strategies and Risk Management21:14 Regional Differences in Medical Investment23:02 International Consulting and Global Perspectives25:32 Cultural Insights from Global Experiences26:59 The Shark Tank Experience: Reality vs. TV29:21 The Rigorous Selection Process for Entrepreneurs31:33 Challenges in Startup Growth and Team Dynamics33:14 Funding Roadblocks and Cultural Differences37:11 Success Stories: From Struggles to Triumphs40:53 The Future of Investment: Incubators and Mentorship44:13 The Importance of Character in Entrepreneurship46:25 Investor Perspectives on Entrepreneurial SuccessGuest Information:Guest's Name: Dr. Kevin ScanlonGuest's Title/Position: Founder & CEO of International BioScience Guest's Linkedin: https://www.linkedin.com/in/kjscanlon/Company/Affiliation: Pasadena Angels https://www.linkedin.com/company/pasadena-angels/Guest's Bio: Dr. Kevin Scanlon is a seasoned leader in life sciences, with a career spanning academic medicine, executive roles in biotech and pharma, and active angel investing. Recognized by LA Techweek for his impact on the Los Angeles tech and business landscape, he served as Chairman of the Pasadena Angels, where nearly 100 investors funded over 50 companies during his tenure.Dr. Scanlon has led four biotech companies as CEO, including Melanoma Diagnostics, acquired by Myriad Genetics. At Berlex-Schering AG, he oversaw global genomic and oncology programs across the US, Europe, and Asia.His academic credentials include being a Leukemia Society Scholar, recipient of the Paul Martini Medical Research Prize (Germany), and co-founding editor of Cancer Gene Therapy (Nature Publishing Group). He has served as President of the International Society of Cell and Gene Therapy and authored 139 peer-reviewed papers, nine medical books, and seven U.S. patents. Dr. Scanlon is also the author of The Hybrid Entrepreneur. TakeawaysCharacter is crucial for entrepreneurial success.Investors look for strong team dynamics.Mentorship can significantly impact startup growth.Understanding investor vocabulary is essential for entrepreneurs.Trust issues can hinder investor-entrepreneur relationships.A strong team can pivot and adapt to challenges.Financial strategy is often a weak point for entrepreneurs.Communication of complex ideas is vital for success.Cultural differences can create friction in teams.Success stories often come from perseverance and adaptability.

In this episode, Naomi Cosman, Global Head of Marketing and Investor Relations at Koning, discusses the revolutionary breast imaging technology offered by Koning. The conversation covers the importance of patient comfort, the challenges of industry resistance, and the need for early detection of breast cancer. Naomi shares insights on marketing strategies, the role of mobile units in increasing accessibility, and the ongoing challenges with insurance coverage. The episode emphasizes the significance of integrating marketing across departments and the passion behind working in healthcare startups.00:00 Introduction to Koning Health and Breast Imaging Innovation02:30 Revolutionizing Breast Imaging: The Koning Vera Breast CT05:47 The Importance of Early Detection and Patient Comfort10:20 Overcoming Industry Resistance and Adoption Challenges15:49 Mobile Units and Accessibility in Breast Imaging20:43 Marketing Strategies: Engaging Patients and Physicians25:57 Insurance Challenges and Cost of Exams30:22 The Startup Culture and Passion for Healthcare35:59 Balancing Technology and Human Connection in Marketing40:24 Conclusion and Call to Action for Breast Health AwarenessGuest Information:Guest's Name:  Naomi CosmanGuest's Title/Position: Global Head of Marketing & Investor RelationsGuest's Linkedin: https://www.linkedin.com/in/naomicosman/ Company/Affiliation: Koning Health https://www.koninghealth.com/Guest's Bio: Naomi Cosman is the Global Head of Marketing at Koning, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin-Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School. She brings over a decade of experience—five years at a Fortune 500 company in branding and campaign management, followed by five years with startups across various sectors. At Koning, Naomi partners with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare.

In this episode, Dr. Axa Yox shares her journey from biotechnology to nutrition, revealing how a deeper understanding of biochemistry, diet, and environment can unlock better health and longevity. She opens up about personal setbacks, the challenges of building a brand in the wellness space, and the critical role of educating people on the science behind nutrition. From insulin regulation to intermittent fasting and mindful eating, Axa offers practical insights to help listeners make empowered, informed decisions about their health.Chapters:00:00 Introduction to Dr. Oksa Jox02:11 Journey from Biotechnology to Nutrition04:30 Learning from Failures08:20 The Importance of Market Understanding10:07 Building a Personal Brand18:22 Explaining the Mechanisms of Healthy Eating26:32 The Role of Environment in Health30:03 Understanding Insulin and Glucose Metabolism32:56 The Importance of Intermittent Fasting36:05 Personal Health Transformations Through Diet39:02 The Misconceptions of Food Labels41:54 Building a Personal Brand in Health46:06 Future Aspirations and Growth in Health Coaching48:02 Stress Management and Breathing Techniques52:11 The Concept of Promises and Personal GrowthGuest Information:Guest's Name: Dr. Axa YoxGuest's Title/Position: Fouder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/dr-axa-yox/Company/Affiliation: X Theory Inc https://x-theory.kit.com/1e03b15cdcGuest's Bio: Dr. Axa Yox is a former scientist turned transformational speaker, author, and LinkedIn strategist. With a PhD in Microbiology and Genetics and a career marked by international fellowships and groundbreaking research, she has authored over 45 scientific papers and holds 12 inventions. Now based in Miami, she’s the founder of X Theory, host of the W.H.Y. – What How Y podcast, and author of Foolfilled Life, a motivational guide to rewiring the brain to overcome anxiety and procrastination. A TEDx 2025 speaker-in-prep and executive contributor at BRAINZ Magazine, Axa brings deep scientific insight to personal development, branding, and the psychology of change.

In this episode, Len May, CEO of EndoDNA, joins Heath Fletcher to explore the future of personalized medicine through genetic testing. They dive into the challenges of innovating within the healthcare market, the role of lifestyle and genetics in preventative care, and the critical importance of understanding the endocannabinoid system. Len shares personal stories that highlight the transformative potential of precision health, the need to overcome stigma around cannabis, and the power of partnerships in driving research. The conversation also reflects on mentorship, personal influences, and how music shapes both life and work.Guest Information:Guest's Name: Len MayGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/lenmay/ Company/Affiliation: EndoDNAGuest's Bio: Len May is a pioneer in personalized wellness, combining over 25 years of experience in genomics, epigenetics, and the endocannabinoid system. As the CEO of EndoDNA, he leads the development of a patented platform that uses DNA to deliver personalized health insights, supported by the world’s largest real-world efficacy dataset. A global authority on medicinal cannabis and precision health, Len is also a published author, international speaker, and host of the podcast Everything is Personal. His books Making Cannabis Personal and ADD is a Superpower highlight his commitment to reshaping healthcare through personalization. Len’s work continues to shape the future of individualized medicine, making healthcare truly personal.Links and Resources:Podcast: Everything is Personal Books: Making Cannabis Personal / ADD is a SuperpowerWebsite: https://www.lenmaycoaching.com/

In this episode, Heath Fletcher sits down with Dr. Jay Sanders, the “Father of Telemedicine,” to explore how technology is reshaping healthcare. From the early days of telemedicine to the integration of AI and electronic medical records, Dr. Sanders shares his visionary insights on the future of medicine. They discuss the economic impact on rural hospitals, the importance of cybersecurity, and why anticipatory, patient-driven care is key to the next evolution in healthcare.Chapters00:00 Introduction to Jay Sanders and Telemedicine05:05 The Evolution of Telemedicine10:02 Economic Impact of Telemedicine on Rural Healthcare15:04 The Role of AI in Medicine20:12 Current Work and Future of Telemedicine25:06 The Future of Healthcare: Anticipatory Medicine27:55 Leveraging Technology for Patient Care30:02 AI in Medical Decision Making31:59 Cybersecurity in Healthcare Data34:10 The Future of Healthcare Post-Pandemic41:01 Innovations in Telemedicine and AI45:57 The Vision for Future HealthcareGuest Information:Guest's Name: Dr. Jay H. SandersGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/jay-sanders-m-d-9618771/.  Company/Affiliation: The Global Telemedicine GroupGuest's Bio: Dr. Jay H. Sanders, known as the “Father of Telemedicine,” is the CEO of The Global Telemedicine Group and Adjunct Professor of Medicine at Johns Hopkins. He founded the American Telemedicine Association and pioneered numerous telemedicine innovations, including the first statewide system and telemedicine kiosk. A Harvard Medical School graduate and former Chief Medical Resident at Massachusetts General Hospital, Dr. Sanders has advised organizations like NASA, DOD, WHO, and the White House. His career spans groundbreaking work in digital health, policy, and global telemedicine strategy.Links and Resources:Co-Author of the Book Digital Medical HomeAvailable on Amazon: https://www.amazon.ca/Digital-Medical-Home-Telemedicine-Revolution/dp/B0BRDDJGKYTakeawaysThe term 'telemedicine' was coined in 1969 during a project at Massachusetts General Hospital.Telemedicine can significantly improve healthcare access in rural areas.Economic factors play a crucial role in the sustainability of rural hospitals.AI has the potential to surpass human physicians in certain areas of healthcare.The best examination of a patient occurs in their home environment.Telemedicine has evolved from using microwave antennas to modern telecommunications.COVID-19 accelerated the acceptance and payment for telemedicine services.Healthcare needs to shift from reactionary to anticipatory models.Genetic analysis should be integrated into routine healthcare practices. Leveraging technology can significantly improve patient care.AI can assist in making informed medical decisions.Cybersecurity is a critical concern for healthcare data.The pandemic has accelerated changes in healthcare delivery.Patients need to take more responsibility for their health.Telemedicine is becoming a standard practice in healthcare.Integrating genetics into healthcare can enhance treatment specificity.Healthcare systems must adapt to new technologies for better outcomes.Access to healthcare is essential, but accuracy is equally important.The future of healthcare will rely on innovative technologies and patient engagement.

In this episode, Dan Goldberger, CEO of electricCore, explores the company’s innovative use of non-invasive vagus nerve stimulation to treat conditions such as headaches, PTSD, and other medical issues. He emphasizes the strong safety profile of their technology and its potential in the growing field of bioelectronic medicine. Dan explains the foundational concept of the body’s electrical systems and how bioelectronics offer an alternative to traditional pharmaceuticals. He also shares perspectives on leadership, company culture, and the challenges of marketing in healthcare, along with thoughts on the role of AI and automation in the future of health tech and personal career insights.Special Podcast Offer: 10% truvaga discount code HEALTH1000:00Introduction to Electric Core and Its Innovations04:48Understanding Vagus Nerve Stimulation10:00The Impact of Headaches and PTSD15:02Leadership Lessons and Building Culture19:59The Future of Bio-Electronic Medicine21:06The Electrical Nature of the Human Body28:29Marketing Evolution in Healthcare33:59Navigating AI and Automation in Health Tech37:32Reflections on Career and Life LessonsGuest Information:Guest's Name: Dan GoldbergerGuest's Title/Position: Chief Executive Officerhttps://www.linkedin.com/in/goldbergerdan/Company/Affiliation: electroCoreGuest's Bio: Dan Goldberger is a highly accomplished C-level executive with over 25 years of leadership experience, known for driving revenue growth and organizational success in the life sciences and healthcare sectors. He has built a strong reputation for leading turnaround initiatives, cultivating high-performance cultures, and spearheading product innovation in competitive, highly regulated industries including biotech, high tech, and medical technology. Links and Resources:electroCore Website: https://www.electrocore.com/Special Podcast Offer: 10% truvaga discount code HEALTH10Key TakeawaysThe company offers products for treating headaches and is expanding into PTSD treatment.Vagus nerve stimulation has a wide range of potential applications in medicine.The technology has a benign safety profile with minimal side effects.Leadership is about surrounding yourself with the right people and building a strong culture.Listening is a crucial skill for effective leadership and learning.Embracing change is essential for resilience in business.The future of bio-electronic medicine is promising and innovative.Dan emphasizes the importance of leading by example in building company culture.The conversation highlights the liberating potential of electricCore's products for patients. The human body operates as an electrical machine.Bioelectronics is an emerging field in healthcare.The vagus nerve plays a crucial role in balance.Stimulating the vagus nerve can restore homeostasis.Marketing in healthcare is increasingly complex.AI is not yet a strategic focus for their company.Direct consumer access to health tech is growing.Ethics and morality are vital in business.Career reflections emphasize the importance of relationships.Helping others is the core motivation in health tech.

In this conversation, Heath Fletcher and Real Rousseau explore the concept of fractional management, particularly in the context of C-suite roles. Real shares his extensive background in engineering and business management, discussing how fractional executives can provide expertise at a fraction of the cost of full-time hires. The discussion covers the benefits of fractional engagement, the differences between fractional executives and consultants, and the strategic planning processes that fractional executives can help implement. Real emphasizes the importance of structure in creativity and how fractional executives can help businesses grow by providing accountability and expertise.Chapters00:00Introduction to Fractional Management02:56The Rise of Fractional Executives05:57Benefits of Fractional C-Suite Engagement08:59Identifying the Right Time for Fractional Support11:59Strategic Planning and Implementation14:49The Role of Fractional Executives in Growth18:02Leveraging Experience Across Industries20:57Conclusion and Future of Fractional ManagementGuest Information:Guest's Name: Real RousseauGuest's Title/Position: Chief Strategy Officerhttps://www.linkedin.com/in/real-rousseau-5b150422/Company/Affiliation: Bullzeye Media MarketingGuest's Bio: Real Rousseau is a seasoned business growth strategist with over 20 years of executive leadership experience spanning CEO, COO, and Business Development roles. He specializes in helping companies unlock revenue potential, streamline operations, and lead high-performing sales and marketing teams. Known for delivering measurable results—such as doubling revenue and boosting profit margins by 30% in just 12 months—Real combines strategic vision with operational expertise to drive sustainable business success.TakeawaysFractional management offers executive expertise at a lower cost.The rise of fractional executives coincided with the COVID-19 pandemic.Fractional executives are part of the team, unlike consultants.Hiring junior staff may not always provide the needed expertise.Fractional executives can help identify when a business needs support.Strategic planning is crucial for business growth and accountability.Fractional executives can help implement financial processes and budgeting.AI tools can assist but cannot replace the need for human expertise.Fractional roles can evolve as the business grows and changes.Collaboration between fractional executives and business owners enhances growth.

In this episode, we interview David Esposito, an experienced healthcare CEO with a background in both large pharma and early-stage biotech. David discusses his career journey, insights into leading and scaling healthcare companies, and the challenges and opportunities in developing innovative therapies for diseases of the eye. He also shares his perspective on leadership, team building, and the importance of maintaining a focus on patient outcomes.Chapters/Timestamps:00:00 - Introduction and David Esposito's Background02:09 - ONL Therapeutics and its Focus09:05 - David Esposito’s Career Journey24:47 - Leadership and Team Building32:35 - Challenges in Biotech and Company Growth48:22 - Marketing and Clinical Trial Enrollment58:52 - Funding and Future Outlook1:09:09 - Inspiration and Advice1:19:31 - The Future of Healthcare InnovationGuest Information:Guest's Name: David EspositoGuest's Title/Position: CEOCompany/Affiliation: ONL TherapeuticsGuest's Bio: David Esposito is an experienced healthcare CEO with over thirty years in the industry. He has a background in large pharma and has built and scaled multiple early to mid-stage life science companies. Currently, he is the CEO of ONL Therapeutics, a mid-stage biotech company focused on developing therapies for diseases of the eye.Links and Resources:ONL Therapeutics: https://onltherapeutics.com/RA Capital: https://www.racap.com/Andreessen Horowitz: https://a16z.com/

In this episode, we interview Dr. Alena Butkevica, an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. Dr. Butkevica shares her journey from reconstructive surgery to developing a line of skincare products designed to boost natural body regeneration and provide alternatives to invasive procedures. She discusses the science behind her products, the importance of high-quality ingredients, and her passion for helping people achieve healthy skin.Chapters/Timestamps:00:00 - Introduction and Dr. Alena Butkevica's Background    10:00 - Dr. Alena Butkevica's Career and Surgical Experience    37:00 - Explanation of Circulation and the Effects of Aging    55:00 - Development of AB Bio Products    1:20:00 - Discussion on Skincare Ingredients and Product Application    1:40:00 - The Future of AB Bio and the Importance of Marketing    Guest Information:Guest's Name: Dr. Alena ButkevicaGuest's Title/Position: MD, DMD, PhD, CEO, and Lead ResearcherCompany/Affiliation: AB Bio InnovationsGuest's Bio: Dr. Alena Butkevica is an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. With a background in medical science and a passion for helping people, she has created a line of award-winning skincare products that offer scientifically proven solutions for various skin concerns.    

In this episode, we interview Dr. Ethan Perlstein, founder and CEO of Curetopia, about his mission to end rare genetic diseases. Dr. Perlstein shares his journey as a scientist, builder, and investor, and discusses Curetopia's innovative approach to drug development, including the use of blockchain and Web3 technologies. He emphasizes the urgency of addressing rare diseases and the need for new models to accelerate the search for cures.Chapters/Timestamps:00:00 - Introduction and Dr. Ethan Perlstein's Background    08:50 - The Challenge of Rare Diseases    21:25 - Curetopia's Mission and Approach    31:54 - Blockchain and the Future of Drug Development    40:09 - The Future of Curetopia and Rare Disease ResearchGuest Information:Guest's Name: Dr. Ethan PerlsteinGuest's Title/Position: Founder and CEOCompany/Affiliation: CuretopiaGuest's Bio: Dr. Ethan Perlstein is a scientist, builder, and investor with a focus on developing cures for rare genetic diseases. He is the founder and CEO of Curetopia, a company utilizing innovative approaches to drug development and funding.Links and Resources:Curetopia Website: https://www.curetopia.xyz/Curetopia on Telegram: https://t.me/curetopiaCuretopia on X (Twitter): https://x.com/endrarediseasesKey Takeaways/Highlights:Dr. Perlstein's background as a scientist and his transition into building and investing in biotech companies.The challenges and misconceptions surrounding rare diseases, including their prevalence and the lack of financial incentive for research.Dr. Perlstein's motivation for focusing on rare diseases, inspired by his interaction with parents of affected children.Curetopia's mission to end rare diseases through innovative drug development strategies.The potential of blockchain and Web3 technologies to transform drug development, including funding, data sharing, and community engagement.Dr. Perlstein's vision for a more collaborative and accelerated approach to finding cures for rare diseases.

In this episode, we interview Kerchanin Allen, a marketing expert with ten years of experience in the healthcare industry. Kerchanin discusses her journey from journalism to healthcare marketing, sharing insights on the unique challenges and opportunities in this dynamic field. She emphasizes the importance of strategic marketing, storytelling, and adapting to the evolving landscape of healthcare, including the use of AI.Chapters/Timestamps:00:00 - Introduction and Kerchanin Allen's Background    09:02 - Strategic Marketing and Storytelling    21:25 - Marketing to Diverse Audiences    31:54 - AI in Healthcare Marketing    40:09 - Sales and Marketing Alignment    47:04 - Advice for Healthcare Marketers and Final Thoughts    Guest Information:Guest's Name: Kerchanin AllenGuest's Title/Position: Marketing ExpertGuest's Linkedin: https://www.linkedin.com/in/kerchanina/Guest's Bio: Kerchanin Allen is a marketing expert with over ten years of experience implementing marketing strategies for organizations in the healthcare space. Her experience spans payer level, utilization management, care coordination, and ACO REACH.    Key Takeaways/Highlights:Kerchanin Allen's background in journalism and how it informs her approach to marketing.    The importance of strategic versus cosmetic marketing in healthcare.    Challenges and strategies for marketing to diverse audiences (patients, providers, investors).    The role of storytelling and creating cohesive brand narratives.    Navigating compliance and legal considerations in healthcare marketing.    The impact of AI on marketing and its potential in the healthcare sector.    The importance of collaboration between sales and marketing teams.    Advice for healthcare marketers: be adaptable, embrace calculated risks, and be persistent.      

In this episode, we interview Jessica Gibson, CEO and co-founder of Aerial Precision Medicine, about the company's innovative approach to precision medicine. Jessica discusses her journey from studying emergency medicine to leading a company that's using genetics and AI to transform the diagnosis and treatment of chronic diseases. She highlights the importance of addressing the root cause of diseases, the challenges of navigating the healthcare system, and Aerial's work in developing targeted therapies to improve patient outcomes.Chapters/Timestamps:00:00 - Introduction and Jessica Gibson's Background08:50 - Ariel Precision Medicine and its Mission21:25 - The Role of AI and Technology in Precision Medicine31:54 - Addressing Challenges in Healthcare and Drug Development40:09 - Marketing and Collaboration Strategies47:04 - Jessica Gibson's Vision for the Future of Aerial Precision MedicineGuest Information:Guest's Name: Jessica GibsonGuest's Title/Position: CEO and CofounderGuest's Company/Affiliation: Aerial Precision MedicineGuest's Bio: Jessica Gibson is the CEO and co-founder of Aerial Precision Medicine. With a background in medicine and science, she transitioned into business and management to drive innovation in healthcare and improve patient outcomes.Links and Resources:Aerial Precision Medicine Website: https://arielmedicine.com/Jessica Gibson LinkedIn: https://www.linkedin.com/in/jessica-gibson-80426124National Pancreas Foundation: https://nationalpancreasfoundations.org/Rebecca's Wish: https://rebeccaswish.org/Mission Cure: https://mission-cure.org/Key Takeaways/Highlights:Jessica Gibson's journey from emergency medicine and gastroenterology research to leading Aerial Precision Medicine.Aerial Precision Medicine's focus on using genetics and AI to understand the root causes of chronic diseases.The challenges of the "diagnostic odyssey" for patients with digestive and metabolic diseases.How Aerial Precision Medicine's technology helps to streamline the diagnosis process and personalize treatment plans.The importance of data quality and human oversight in the use of AI in healthcare.Aerial Precision Medicine's approach to drug development, starting with a deep understanding of the disease.The company's emphasis on collaboration with healthcare providers, researchers, and pharmaceutical companies.Jessica Gibson's insights on leadership, company growth, and navigating the complexities of the healthcare industry.

In this episode, we interview Joe Banach, Director of Sales and Marketing at Next Step Robotics, about the innovative use of robotics in rehabilitation. Joe shares his unique career path from personal trainer and physical therapist to the health tech industry. He discusses Next Step Robotics' approach to rehabilitation, emphasizing patient contribution to movement and the importance of data-driven outcomes. Joe also provides insights into the challenges of marketing novel technology in the healthcare space and strategies for overcoming them.Chapters/Timestamps:00:00 - Introduction and Joe's Background02:59 - Next Step Robotics and the AMBL Device05:50 - The Role of Data in Therapy09:02 - Sales and Marketing Strategies in Healthcare12:06 - Challenges in Educating the MarketGuest Information:Guest's Name: Joe BanachGuest's Title/Position: Director of Sales and MarketingGuest's Company/Affiliation: Next Step RoboticsGuest's Bio: Joe Banach is the Director of Sales and Marketing at Next Step Robotics. With a background as a physical therapist, Joe is dedicated to advancing rehabilitation through the use of innovative robotic technology and improving patient outcomes.Links and Resources:Next Step Robotics Website: www.nextsteprobo.comLinkedIn: https://www.linkedin.com/in/joseph-banach-pt-dpt-ocs/Book Recommendation: The Sales Acceleration Formula by Mark RobergeBook Recommendation: Never Split The Difference by Chris VossKey Takeaways/Highlights:Joe Banach's unconventional journey from personal trainer to Director of Sales and Marketing.Next Step Robotics' AMBL device and its focus on patient-contributed movement.The importance of supplementing traditional therapy with robotic technology to increase dosage and improve outcomes.The role of neuroplasticity and cognitive engagement in effective rehabilitation.Using data and gamification to motivate patients and track progress.Challenges in educating the market and building trust for new rehabilitation technologies.Sales strategies for navigating long sales cycles and competing in the health tech industry.The impact of therapist turnover on the adoption of new technologies in rehab clinics.

Join host Heath Fletcher on The Healthy Enterprise as he explores how healthcare leaders and innovators are transforming the industry from the inside out. Whether you’re a provider, tech entrepreneur, marketing strategist, or industry executive, these conversations deliver actionable strategies, innovative solutions, and human-centered insights to help you grow, lead, and make a lasting impact.This podcast was created and produced by Bullzeye Media Marketing. Let’s make something great together!